THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 143 filers reported holding THERAVANCE INC in Q2 2014. The put-call ratio across all filers is 0.76 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2014 | $1,150,000 | -68.8% | 67,300 | -45.7% | 0.01% | -66.7% |
| Q2 2014 | $3,690,000 | +3.1% | 123,900 | +7.1% | 0.02% | 0.0% |
| Q1 2014 | $3,580,000 | -25.7% | 115,700 | -14.4% | 0.02% | -28.0% |
| Q4 2013 | $4,816,000 | -9.9% | 135,100 | +3.3% | 0.02% | -16.7% |
| Q3 2013 | $5,348,000 | +9.3% | 130,800 | +3.0% | 0.03% | +7.1% |
| Q2 2013 | $4,893,000 | – | 127,000 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baupost Group | 20,395,056 | $607,365,000 | 9.89% |
| Realm Partners LLC | 301,521 | $8,979,000 | 3.75% |
| CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD | 2,805,837 | $83,558,000 | 2.52% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 7,447,743 | $221,794,000 | 2.27% |
| SECTORAL ASSET MANAGEMENT INC | 1,743,188 | $51,912,000 | 2.20% |
| Foundation Asset Management, LP | 255,790 | $7,617,000 | 2.19% |
| Proxima Capital Management, LLC | 550,000 | $16,379,000 | 1.93% |
| Roundview Capital LLC | 140,645 | $4,188,000 | 1.69% |
| BB BIOTECH AG | 933,244 | $27,792,000 | 1.32% |
| PERRY CAPITAL | 1,517,208 | $45,182,000 | 1.25% |